A 38-year-old man from Delhi with a 10-year history of Type 2 diabetes (managed with metformin and glibenclamide) presents with recurrent episodes of diabetic ketoacidosis (DKA) over the past 2 years, despite good medication adherence and no recent infections. His BMI is 22 kg/m², and he has no family history of diabetes. Serum C-peptide is 0.6 ng/mL. Anti-GAD65 antibodies are strongly positive. What is the most likely explanation for the recurrent DKA episodes in this patient?

Explanation

## Diagnosis: LADA Misclassified as Type 2 Diabetes ### Clinical Context This patient was initially labeled as having Type 2 diabetes (likely due to adult age at presentation), but is now manifesting recurrent DKA — a hallmark of absolute insulin deficiency. The key clue is the **positive anti-GAD65 antibody** and **low C-peptide**, indicating autoimmune beta cell destruction. ### Pathological Mechanism: Progressive Autoimmune Beta Cell Loss **Key Point:** LADA is a slowly progressive autoimmune diabetes that can masquerade as Type 2 diabetes in middle-aged adults. Over years, autoimmune destruction of beta cells leads to absolute insulin deficiency, eventually requiring insulin therapy and becoming prone to DKA. ### Timeline of Pathological Events ```mermaid flowchart TD A[Genetic predisposition + Environmental trigger]:::outcome --> B[Autoimmune infiltration of islets<br/>CD8+ T cells, macrophages]:::action B --> C[Gradual beta cell apoptosis]:::action C --> D[Years 1-5: Insulin resistance pattern<br/>Controlled on oral agents]:::outcome D --> E[Years 5-10: Progressive beta cell loss<br/>Declining C-peptide]:::action E --> F[Years 10+: Absolute insulin deficiency<br/>Recurrent DKA, requires insulin]:::urgent G[Anti-GAD65, Anti-IA2 positive]:::outcome --> F ``` ### Why DKA Develops Now **High-Yield:** DKA in a Type 2 diabetic patient is a red flag for misclassification as LADA. The mechanism: 1. **Severe beta cell loss** → minimal endogenous insulin production (C-peptide 0.6 ng/mL) 2. **Absolute insulin deficiency** → uncontrolled hyperglycemia despite oral agents 3. **Lipolysis and ketogenesis** → unopposed free fatty acid oxidation in liver 4. **Metabolic acidosis** → DKA develops, especially with minor stressors **Clinical Pearl:** Oral agents (metformin, sulfonylureas) cannot prevent DKA when beta cells are destroyed. Insulin therapy becomes mandatory. ### Diagnostic Clues for LADA Misclassified as Type 2 | Feature | Suggests LADA, Not Type 2 | |---|---| | **Age at diagnosis** | Adult (30–50 years), not obese | | **BMI** | Normal or lean (22 in this case) | | **Autoantibodies** | Positive (anti-GAD65, anti-IA2, anti-ZnT8) | | **C-peptide** | Low or declining | | **Response to oral agents** | Initial control, then failure | | **Acute presentations** | DKA, despite oral therapy adherence | | **Family history** | Often absent or weak | **Mnemonic: LADA Red Flags = "ADULT LEAN ANTIBODY"** - **A**dult onset (not childhood) - **D**ecline in C-peptide over time - **U**nusual for Type 2 (lean, non-obese) - **L**ow insulin requirement initially, then high - **T**ype 1 autoantibodies present - **L**ate diagnosis (often 5–10 years after symptom onset) - **E**ventual insulin requirement - **A**utoimmune markers (GAD, IA2) - **N**o insulin resistance - **T**herapy failure on oral agents - **I**nsulin deficiency (low C-peptide) - **B**eta cell destruction (insulitis on pathology) - **O**ver time, progressive loss - **D**KA risk increases - **Y**ears of misclassification ### Why Option 0 Is Correct The positive anti-GAD65 antibody and low C-peptide confirm autoimmune beta cell destruction (LADA), not Type 2 diabetes. Over 10 years, progressive loss of beta cells has led to absolute insulin deficiency, explaining the recurrent DKA. The patient was misclassified as Type 2 at diagnosis because of adult age and initial response to oral agents. [cite:Robbins 10e Ch 24; Harrison 21e Ch 377]